31 August - 04 September 2019, Paris - France

Session Details

Hot Line Session 1
Sun 01 Sep 14:30 - 16:10 European Society of Cardiology - Other Late-Breaking Science, Mobile App - Ask a Question Paris - Main Auditorium
Chairpersons: Barbara CASADEI (Oxford, United Kingdom of Great Britain & Northern Ireland), Stephan ACHENBACH (Erlangen, Germany), Marco ROFFI (Geneva, Switzerland)

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
14:302097THEMIS - Main Results of the Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study Deepak BHATT (Newton, United States of America)
14:432098THEMIS-PCI: Ticagrelor in Patients with Diabetes and Stable Coronary Artery Disease with a History of Prior Percutaneous Coronary InterventionPhilippe Gabriel STEG (Paris, France)
14:562099Discussant review - THEMIS/THEMIS-PCIColin BAIGENT (Oxford, United Kingdom of Great Britain & Northern Ireland)
15:002100Questions from the audience and discussion 
15:042101PARAGON-HF - Angiotensin Receptor Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionScott SOLOMON (Boston, United States of America)
15:172102Discussant review - PARAGON-HF.Stuart J CONNOLLY (Hamilton, Canada)
15:212103Questions from the audience and discussion. 
15:252104COMPLETE Revascularization with Multivessel Percutaneous Coronary Intervention in ST-segment Elevation Myocardial InfarctionShamir R MEHTA (Hamilton, Canada)
15:382105Discussant review - COMPLETE.Stefan JAMES (Uppsala, Sweden)
15:422106Questions from the audience and discussion. 
15:46 DAPA HF - The Dapagliflozin And Prevention Of Adverse-outcomes In Heart Failure TrialJohn J V MCMURRAY (Glasgow, United Kingdom of Great Britain & Northern Ireland)
15:59 Discussant review - DAPA-HF.Marco METRA (Brescia, Italy)